Stratec SE (SBS) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.004x

Based on the latest financial reports, Stratec SE (SBS) has a cash flow conversion efficiency ratio of 0.004x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.00 Million ≈ $1.17 Million USD) by net assets (€237.32 Million ≈ $277.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SBS defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Stratec SE - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Stratec SE's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Stratec SE Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Stratec SE ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Aspo Oyj HE:ASPO	0.157x
Kg Chemical KO:001390	0.042x
Compagnie Du Mont-Blanc PA:MLCMB	0.078x
GCT Semiconductor Holding Inc NYSE:GCTS	0.100x
Kejuruteraan Asastera Bhd KLSE:0193	-0.273x
Akmerkez Gayrimenkul Yatirim Ortakligi AS IS:AKMGY	0.014x
T'way Air Co Ltd KO:091810	0.196x
Immersion Corporation NASDAQ:IMMR	-0.060x

Annual Cash Flow Conversion Efficiency for Stratec SE (2002–2025)

The table below shows the annual cash flow conversion efficiency of Stratec SE from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see SBS company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€237.32 Million ≈ $277.45 Million	€-433.00K ≈ $-506.22K	-0.002x	-100.91%
2024-12-31	€242.53 Million ≈ $283.55 Million	€48.71 Million ≈ $56.95 Million	0.201x	+141.25%
2023-12-31	€233.33 Million ≈ $272.78 Million	€19.43 Million ≈ $22.71 Million	0.083x	+82.38%
2022-12-31	€225.18 Million ≈ $263.26 Million	€10.28 Million ≈ $12.02 Million	0.046x	-85.20%
2021-12-31	€205.76 Million ≈ $240.55 Million	€63.47 Million ≈ $74.21 Million	0.308x	+67.12%
2020-12-31	€172.54 Million ≈ $201.72 Million	€31.85 Million ≈ $37.23 Million	0.185x	+38.04%
2019-12-31	€159.01 Million ≈ $185.90 Million	€21.26 Million ≈ $24.86 Million	0.134x	+70.31%
2018-12-31	€152.20 Million ≈ $177.94 Million	€11.95 Million ≈ $13.97 Million	0.079x	-58.67%
2017-12-31	€157.84 Million ≈ $184.53 Million	€29.98 Million ≈ $35.05 Million	0.190x	+67.93%
2016-12-31	€143.72 Million ≈ $168.02 Million	€16.26 Million ≈ $19.00 Million	0.113x	-43.40%
2015-12-31	€130.28 Million ≈ $152.31 Million	€26.03 Million ≈ $30.44 Million	0.200x	-43.67%
2014-12-31	€112.05 Million ≈ $131.00 Million	€39.75 Million ≈ $46.47 Million	0.355x	+44.63%
2013-12-31	€97.18 Million ≈ $113.61 Million	€23.84 Million ≈ $27.87 Million	0.245x	+729.52%
2012-12-31	€91.98 Million ≈ $107.54 Million	€2.72 Million ≈ $3.18 Million	0.030x	-77.01%
2011-12-31	€83.23 Million ≈ $97.31 Million	€10.71 Million ≈ $12.52 Million	0.129x	+538.58%
2010-12-31	€71.88 Million ≈ $84.03 Million	€1.45 Million ≈ $1.69 Million	0.020x	-89.02%
2009-12-31	€59.29 Million ≈ $69.31 Million	€10.88 Million ≈ $12.72 Million	0.183x	+95.22%
2008-12-31	€49.90 Million ≈ $58.34 Million	€4.69 Million ≈ $5.48 Million	0.094x	-52.28%
2007-12-31	€48.58 Million ≈ $56.79 Million	€9.57 Million ≈ $11.19 Million	0.197x	-10.44%
2006-12-31	€40.13 Million ≈ $46.92 Million	€8.83 Million ≈ $10.32 Million	0.220x	+430.06%
2005-12-31	€31.52 Million ≈ $36.85 Million	€1.31 Million ≈ $1.53 Million	0.041x	-73.32%
2004-12-31	€15.47 Million ≈ $18.08 Million	€2.41 Million ≈ $2.81 Million	0.156x	+384.79%
2003-12-31	€12.87 Million ≈ $15.05 Million	€413.00K ≈ $482.84K	0.032x	-99.98%
2002-12-31	€11.17K ≈ $13.06K	€1.73 Million ≈ $2.03 Million	155.162x	--

About Stratec SE

XETRA:SBS Germany Medical Devices

Market Cap

$262.91 Million

€224.88 Million EUR

Market Cap Rank

#16381 Global

#1558 in Germany

Share Price

€18.50

Change (1 day)

+1.31%

52-Week Range

€16.52 - €32.00

All Time High

€139.81